BeOne Medicines
ONC
#625
Rank
$40.73 B
Marketcap
$358.07
Share price
-0.20%
Change (1 day)
3.93%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2026 (TTM): $1.02 Billion USD

According to BeOne Medicines's latest financial reports the company's current earnings are $6.12 Billion USD. In 2025 the company made an earning of $0.51 Billion USD, an increase over its 2024 earnings that were of -$0.57 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $1.02 B99.47%
2025 $0.51 B-190.03%
2024 -$0.57 Billion-52.95%
2023 -$1.21 Billion-32.52%
2022 -$1.79 Billion24.39%
2021 -$1.44 Billion-13.21%
2020 -$1.66 Billion72.69%
2019 -$0.96 Billion36.01%
2018 -$0.71 Billion616.83%
2017 -$98.46 Million-15.24%
2016 -$0.12 Billion107.91%
2015 -$55.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-$79.83 Million-107.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-$18.16 Million-101.78%๐Ÿ‡บ๐Ÿ‡ธ USA